Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma

Tomohiro Yamaki(Chiba Cancer Center), Akira Nakagawara(Chiba Cancer Center)
Scientific Reports
January 29, 2013
Cited by 25


Related Papers